Skip to Content
Merck
All Photos(1)

Documents

Safety Information

F2427

Sigma-Aldrich

Fluprostenol isopropyl ester

≥98%, ethanol solution

Synonym(s):

(±)-16-(m-Trifluoromethylphenoxy)tetranorprostaglandin F2, Travoprost

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C26H35F3O6
CAS Number:
Molecular Weight:
500.55
EC Number:
MDL number:
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77

Quality Level

Assay

≥98%

form

ethanol solution

shipped in

wet ice

storage temp.

−20°C

SMILES string

CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COc2cccc(c2)C(F)(F)F

InChI

1S/C26H35F3O6/c1-17(2)35-25(33)11-6-4-3-5-10-21-22(24(32)15-23(21)31)13-12-19(30)16-34-20-9-7-8-18(14-20)26(27,28)29/h3,5,7-9,12-14,17,19,21-24,30-32H,4,6,10-11,15-16H2,1-2H3/b5-3-,13-12+/t19-,21-,22-,23+,24-/m1/s1

InChI key

MKPLKVHSHYCHOC-AHTXBMBWSA-N

Gene Information

human ... PTGFR(5737)

Biochem/physiol Actions

Potent FP prostanoid receptor agonist used in animal models for glaucoma.

Pictograms

FlameExclamation mark

Signal Word

Danger

Hazard Statements

Hazard Classifications

Eye Irrit. 2 - Flam. Liq. 2

Storage Class Code

3 - Flammable liquids

WGK

WGK 2

Flash Point(F)

62.6 °F - closed cup

Flash Point(C)

17 °C - closed cup


Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

FSL

Group 4: Flammable liquids
Alcohols
Hazardous rank II

ISHL Indicated Name

Substances Subject to be Indicated Names

ISHL Notified Names

Substances Subject to be Notified Names

JAN Code

F2427-BULK:
F2427-1MG-PW:
F2427-VAR:
F2427-1MG:4548174015797


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Takashi Kanamoto et al.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 31(3), 156-164 (2015-02-25)
To evaluate some clinically important features of benzalkonium chloride (BAK) toxicity by comparing tafluprost with 0.001% BAK and travoprost preserved with SofZia applied to the ocular surface of the eyes with glaucoma. This was a prospective, randomized, observer unmasked, multicenter
Chengpu Zhang
Pakistan journal of pharmaceutical sciences, 28(2 Suppl), 781-784 (2015-03-23)
This study discussed about the influence of local application of glaucoma medications -- travoprost eye drops to patients' tear film function. We selected 24 patients, 45 eyes with primary open-angle glaucoma or intraocular hypertension. All of the patients topically used
Shinsaku Yamane et al.
Investigative ophthalmology & visual science, 56(4), 2547-2552 (2015-03-20)
The purpose of this study was to determine whether a better IOP reduction can be observed in conscious, normotensive monkeys treated with ONO-9054, a novel dual EP3 and FP receptor agonist, compared with prostaglandin F2α analogs. The binding affinities and
Joao F Lopes et al.
BMC ophthalmology, 15, 166-166 (2015-11-14)
Prostaglandin analogs reduce intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension; however, these medications may affect the ocular surface and elicit ocular discomfort when preserved with benzalkonium chloride (BAK). This was an open-label, single-arm study conducted in
Katsuyoshi Suzuki et al.
Journal of glaucoma, 24(6), e145-e150 (2013-11-19)
To evaluate the safety and efficacy of benzalkonium chloride (BAK)-optimized tafluprost (with a BAK concentration reduced from 0.01% to 0.001%) in glaucoma patients with existing superficial punctate keratitis (SPK). A prospective, multicenter, open-label study was designed to compare BAK-optimized tafluprost

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service